Quankang Nuo (荃康诺)荃康诺
This is a medicine registration record from NMPA data.本页为国家药监局药品注册记录。
Labeled sections from the recorded Chinese source are included below. English wording is a reference translation when one is on file, not an official English label.本记录未接入产品级适应症/安全性标注字段。
生产企业Manufacturer
- 山东鲁抗医药股份有限公司Chinese legal name: 山东鲁抗医药股份有限公司
主要成分Active Ingredients
- 塞曲司特Saiqu Site
药物知识说明
塞曲司特是一种在国家药监局注册认定的药品。标注生产企业为山东鲁抗医药股份有限公司。
该药品暂无关联的活性成分信息。
该药品标注的生产企业为:山东鲁抗医药股份有限公司Chinese legal name: 山东鲁抗医药股份有限公司、山东鲁抗医药股份有限公司Chinese legal name: 山东鲁抗医药股份有限公司、山东鲁抗医药股份有限公司Chinese legal name: 山东鲁抗医药股份有限公司。
本页面内容来自国家药监局数据库,MedicineGraph在此基础上提供关系图谱和知识导航。
Medicine Knowledge
This medicine (original name: 荃康诺) is a medicine registered with the national drug regulatory authority. It is manufactured by Chinese legal name: 山东鲁抗医药股份有限公司.
No active ingredient relationships are currently recorded for this product in MedicineGraph.
Manufacturers recorded for this product: 山东鲁抗医药股份有限公司Chinese legal name: 山东鲁抗医药股份有限公司, 山东鲁抗医药股份有限公司Chinese legal name: 山东鲁抗医药股份有限公司, 山东鲁抗医药股份有限公司Chinese legal name: 山东鲁抗医药股份有限公司.
Source: MedicineGraph authoritative database. Relationships derived from registered product information.
这是什么What is this
- 通用名/品名Recorded product name: 荃康诺Recorded Chinese name: 荃康诺
- 剂型Dosage form: 片剂Tablets
- 规格Specification: 40mg×6片/板。Recorded Chinese description: 40mg×6片/板。
本段仅展示注册/说明书已记录的身份属性,不含适应症或用法建议。Identity attributes from registration/leaflet records only; no indications or usage advice.
生产企业Manufacturer
- 山东鲁抗医药股份有限公司Chinese legal name: 山东鲁抗医药股份有限公司
注册信息NMPA approval number
- 批准文号NMPA approval number: 国药准字H20070100
关联实体Relationships
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据及已接入说明书字段。National Medical Products Administration (China) medicine-registration data and linked leaflet fields.
- 品名来源Name source: 10多万条药品说明书数据库 (HIGH)Package-insert database (more than 100,000 records) (HIGH)
- 生产企业来源Manufacturer source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
- 剂型来源Dosage-form source: 10多万条药品说明书数据库Package-insert database (more than 100,000 records)
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。不含适应症/安全性推断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence. No inferred indications/safety.
本段为已核准说明书原文摘录(非改写、非AI摘要),非正式英文标签,亦不构成用药建议。 Not an official English label and not medical advice. English wording, when shown, is a reference translation of the Chinese source label.
English translation for reference. Translated from the Chinese source label. Not an official English label and not medical advice.
NMPA approval number
国药准字H20070100
Manufacturer
Chinese legal name: 山东鲁抗医药股份有限公司 (domestically manufactured)
Indications
English translation unavailable. The original Chinese source label remains available below.
Dosage and administration
English translation unavailable. The original Chinese source label remains available below.
Adverse reactions
English translation unavailable. The original Chinese source label remains available below.
Contraindications
English translation unavailable. The original Chinese source label remains available below.
Precautions
English translation unavailable. The original Chinese source label remains available below.
Storage
English translation unavailable. The original Chinese source label remains available below.
Specification
English translation unavailable. The original Chinese source label remains available below.
中文说明书原文Original Chinese source label
批准文号
国药准字H20070100
生产企业
山东鲁抗医药股份有限公司(国产)
适应症
本品适用于治疗轻、中度支气管哮喘。
用法用量
口服,成人一次2片(2×40mg),每日一次,或遵医嘱。本品应在晚饭后服用。
不良反应
极少数病人(小于0.1%)偶见伴随着黄疸,ALT、AST升高的肝功能障碍,还有报道有急性肝炎患者,均应作停药处理。少数病人(在0.1 5%之内)可能出现、1.过敏性症状,如皮疹、搔痒,可停药处理;2.消化系统,如恶心、呕吐、食欲不振、胃部不适、腹痛、腹泻、便秘、口渴;3.血液系统、鼻出血、皮下出血、贫血、嗜酸性细胞增多;4.精神系统、嗜睡、头痛、头晕等;5.其它、倦怠、浮肿、心悸。
禁忌
对本品过敏者禁用。妊娠妇女禁用。
注意事项
1. 本品不同于支气管扩张剂和甾体激素,不能立即缓解已发作的哮喘,而是通过消除各种症状,改善肺功能,从而有效地抑制哮喘的产生和发展。2. 服用本品如出现哮喘大发作,必须给予甾体激素或支气管扩张剂。3. 激素依赖性患者服用本品,应在医生指导下逐渐减少激素用量,不可突然停用。4. 肝功能不全患者服用本品有时会引起黄疸或肝功能异常,并偶见急性肝炎的报告,因此应定期监测肝脏功能。
贮藏
遮光、密闭保存。
规格
40mg×6片/板。
信息来源Source and scope
国家药品监督管理局(中国)药品注册数据。National Medical Products Administration (China) medicine-registration data.
范围:当前 MedicineGraph 注册记录及已记录的精确关系;非完整目录,亦不构成疗效等同主张,也不支持换用判断。Scope: current MedicineGraph registration records and exact recorded relationships; not a complete catalog and not a claim of therapeutic equivalence.